The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.
about
Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapyCumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort StudyThe Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro.Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFupVery small embryonic-like stem cells (VSELs) detected in azoospermic testicular biopsies of adult survivors of childhood cancer.Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.Electrocardiographic abnormalities and mortality in aging survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study.Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.Racial/Ethnic Differences in Adverse Outcomes Among Childhood Cancer Survivors: The Childhood Cancer Survivor Study.Erectile Dysfunction in Male Survivors of Childhood Cancer-A Report From the Childhood Cancer Survivor Study.Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.Longitudinal observation of serum anti-Müllerian hormone in three girls after cancer treatment.Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors.Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort.Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.Autotransplantation of cryopreserved ovarian tissue after treatment for malignant disease - the first Norwegian results.Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study.Acute lymphoblastic leukemia in adolescents and young adults.Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer.Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study.Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†.Specialized survivor clinic attendance is associated with decreased rates of emergency department visits in adult survivors of childhood cancer.Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agentsPrevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes.Gonadal and Sexual Dysfunction in Childhood Cancer Survivors.High risk of hypogonadism in young male cancer survivors.Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro.Ovarian function in female survivors after multimodal Ewing sarcoma therapy.Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapyGenetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
P2860
Q34260518-13C9EEB7-F11E-4F46-8C86-073D02EA2C60Q34317913-7E8A9866-4FA0-4C88-B6E4-D3853CBAEACFQ34491288-DBB14BB8-9610-45ED-B05B-AF3B36253652Q35727027-EBF3DB77-7B26-4A02-AD64-70889B12127FQ36011154-EA093F04-9579-4668-B49A-E2679E57A1AFQ36068659-FD252AE1-8C0C-4D66-8714-96D1797CD1B4Q36137174-BF9075F1-8CCD-4427-B316-BA927762FBD5Q36267649-471E78D2-1684-4FA8-9FDC-6F6C3D843C69Q36372608-3A49B71C-4879-4DC4-A977-972089F667E1Q36408363-8325ED2E-03D0-4D3E-B79F-212564352E0AQ36914353-CA65E6E0-E450-442F-9DFD-D5D3567C66B6Q36915196-DCD00830-27BE-45E4-A8BE-0850385DF628Q36932529-54AEA79A-8BFA-4890-A8FF-0757D7DA4001Q37004233-4AA93154-49E7-4890-8304-D9CB2AD52C43Q37348851-044BC639-DBC5-42C0-BEA7-94A7142C8529Q37588564-7169F077-3AD5-44E1-A703-A16A9CCFEF5FQ38860945-3E079EA5-01A6-4CFC-A74B-AE41E72DA85AQ38937267-5434FC06-B5E0-4E4B-945F-BF113D7243FEQ38993309-E88E3D5C-61C7-4E85-B5EE-C12DB9C24DE7Q39176676-AE5AAB36-565F-4A3E-92C3-299D07BFC8B5Q39192991-EEE7F5E9-DED7-4F98-A763-8C8FDA4977E0Q40003525-AFA1B576-45B4-44BB-AA30-CF5B196692D8Q40152948-2C1EBFF3-4B55-4093-9D4D-B07C7602EC73Q40227501-A840B16D-EC69-4CDD-B296-D5A9B144933DQ40500988-6C0F236A-765B-46C7-98AF-B0FB398357FDQ41843769-316BEE57-219D-4A41-8FA7-B67EECF2082AQ46060181-D3D11C4C-8290-40EF-8585-9C433D2B3A07Q47869940-EA8C69EF-BAD2-4621-9FB2-11EB48687EDBQ48108967-CF38B830-FB50-40C6-BBDB-B05C34E74D45Q48234866-FAB97857-3659-4F35-9B50-F3D52D34846BQ48602762-2E028F25-8D26-468A-A738-8C0369C5F6E9Q49788370-FE129CD1-7EAE-4002-9C3B-0E8F001C2CAAQ50061836-A48FE60D-2F7A-4C4C-981E-237BF2A69553Q50959012-5B1B0F9C-4006-4AA4-BF4C-D7C765EA20C6Q51061203-6E67513B-5559-483E-B5FF-0A9B282F66D0Q52964863-64E1F506-E203-4A33-90CC-EE2F7BA5662FQ57559907-E96F9DDF-5478-4C0C-85F6-862114549C8FQ58695066-4A15B2F3-A09B-452F-9A36-7CF53A8020E2
P2860
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@en
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@nl
type
label
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@en
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@nl
prefLabel
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@en
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@nl
P2093
P2860
P356
P1476
The cyclophosphamide equivalen ...... ildhood Cancer Survivor Study.
@en
P2093
Charles A Sklar
Daniel M Green
DeoKumar Srivastava
John A Whitton
Joseph P Neglia
Leslie L Robison
Lisa R Diller
Marilyn Stovall
Melissa M Hudson
Pamela J Goodman
P2860
P356
10.1002/PBC.24679
P577
2013-08-12T00:00:00Z